Tumor marker analysis revealed an elevated plasma ProGRP level of 268 pg/mL, while CEA and CYFRA levels were within normal limits at 4.7 ng/mL and 1.1 ng/mL, respectively. The gene discussed is GRP; the disease is neoplasm.